You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

Details for Patent: 10,106,579


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,106,579 protect, and when does it expire?

Patent 10,106,579 protects ZILBRYSQ and is included in one NDA.

This patent has ninety-one patent family members in twenty-nine countries.

Summary for Patent: 10,106,579
Title:Modulation of complement activity
Abstract:The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.
Inventor(s):Hoarty Michelle Denise, Dhamnaskar Ketki Ashok, Elbaum Daniel, Josephson Kristopher, Larson Kelley Cronin, Ma Zhong, Nims Nathan Ezekiel, Ricardo Alonso, Seyb Kathleen, Tang Guo-Qing, Treco Douglas A., Wang Zhaolin, Ye Ping, Zheng Hong, Perlmutter Sarah Jacqueline, Hammer Robert Paul
Assignee:Ra Pharmaceuticals, Inc.
Application Number:US15318063
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,106,579: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article delves into the specifics of United States Patent 10,106,579, titled "Modulation of complement activity," to provide a detailed analysis of its scope, claims, and the broader patent landscape.

Overview of the Patent

Patent Number and Title

United States Patent 10,106,579, titled "Modulation of complement activity," was granted to address methods and compositions related to modulating the complement system, a part of the immune system[4].

Publication and Prior Art

The patent was published with the publication number US10106579B2. It includes prior art keywords such as polypeptides, amino acids, and specific chemical compounds, indicating the technical field it pertains to[4].

Scope of the Patent

Claims Analysis

The scope of a patent is primarily defined by its claims. For US Patent 10,106,579, the claims include:

  • Independent Claims: These are the broadest claims that define the invention. They typically include the essential features of the invention.
  • Dependent Claims: These claims are narrower and build upon the independent claims, adding additional features or limitations.

The claims in this patent cover various aspects of modulating complement activity, including specific polypeptides, methods of use, and therapeutic applications[4].

Claim Language and Metrics

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims at publication are often associated with a higher probability of grant and a shorter examination process[3].

Technical Details

Modulation of Complement Activity

The patent describes modulators of complement activity, which are crucial in therapeutic applications. The complement system plays a significant role in immune responses, and its dysregulation can lead to various diseases. The patent outlines methods and compositions for modulating this system, including specific polypeptides and their uses[4].

Chemical and Biological Aspects

The patent includes detailed descriptions of chemical compounds and biological effects, such as inflammatory effects, vascular effects, and ocular diseases. These details are essential for understanding the scope and potential applications of the invention[4].

Patent Landscape

Global Patent System

The patent landscape for US Patent 10,106,579 extends beyond the U.S. borders. The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This service is crucial for understanding the global reach and potential conflicts of the patent[1].

International Search Resources

To fully understand the patent landscape, one must also search international patent databases. Resources such as the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE provide access to international patent applications and machine translations, helping to identify similar inventions globally[1].

Legal and Practical Considerations

Patent Examination and Maintenance

The patent examination process and subsequent maintenance are critical aspects of patent scope. The Patent Examination Data System (PEDS) allows public users to search, view, and download bibliographic data for patent applications, which can help in understanding the examination history and any office actions related to the patent[1].

Potential for Litigation and Licensing

The scope of a patent can significantly impact its potential for litigation and licensing. Broader patents may lead to increased licensing and litigation costs, while narrower claims can reduce these risks. The study on patent scope metrics suggests that narrower claims are associated with a shorter examination process and higher grant probability, which can mitigate some of these risks[3].

Stakeholder Input and Policy Considerations

Small Claims Patent Court

The Administrative Conference of the United States (ACUS) has conducted studies on the feasibility of a small claims patent court, which could impact the enforcement and litigation landscape for patents like US 10,106,579. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes, affecting the overall patent landscape[5].

Public Access and Search Tools

USPTO Search Resources

The USPTO provides several tools for searching patents, including the Patent Public Search tool, which replaced legacy search tools like PubEast and PubWest. This tool offers enhanced access to prior art and improves the overall patent searching process[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for inventors and researchers looking to understand the scope and claims of patents like US 10,106,579[1].

Key Takeaways

  • Claims Definition: The scope of US Patent 10,106,579 is defined by its independent and dependent claims, which cover modulators of complement activity and their therapeutic applications.
  • Global Reach: The patent's global implications can be understood through services like the Global Dossier and international patent databases.
  • Legal Considerations: The patent's examination history, maintenance, and potential for litigation and licensing are crucial for understanding its practical implications.
  • Public Access: Tools like the Patent Public Search and PTRCs are essential for conducting thorough patent searches.

FAQs

What is the main subject of US Patent 10,106,579?

The main subject of US Patent 10,106,579 is the modulation of complement activity, including methods and compositions for therapeutic applications.

How can I search for similar patents globally?

You can use services like the Global Dossier, European Patent Office's esp@cenet, Japan Patent Office, and World Intellectual Property Organization's PATENTSCOPE to search for similar patents globally.

What are the key metrics for measuring patent scope?

Key metrics include independent claim length and independent claim count, which can indicate the breadth and clarity of the patent claims.

Where can I find training in patent search techniques?

You can find training in patent search techniques at your nearest Patent and Trademark Resource Center (PTRC).

What is the significance of the Global Dossier service?

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices, providing a comprehensive view of the global patent landscape.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Google Patents - US10106579B2: https://patents.google.com/patent/US10106579B2/en
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,106,579

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-001 Oct 17, 2023 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Try for Free
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-002 Oct 17, 2023 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Try for Free
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-003 Oct 17, 2023 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,106,579

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3154561 ⤷  Try for Free CA 2024 00021 Denmark ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free 301275 Netherlands ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free PA2024514 Lithuania ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free LUC00343 Luxembourg ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free 2024C/518 Belgium ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.